NEW MODEL TO QUANTIFY THE IN VITRO PHARMACOLOGICAL ACTIVITY OF BI-SPECIFIC ANTIBODIES IN HAEMATOLOGIC MALIGNANCIES

被引：0

作者：

Primo, D. ^{[1
]}

Martinez Cuadron, D. ^{[2
]}

Montesinos, P. ^{[2
]}

De la Serna, J. ^{[3
]}

Ribera, J. Ma ^{[4
]}

Vives, S. ^{[4
]}

Bergua, J. ^{[5
]}

Perez de Oteyza, J. ^{[6
]}

Serrano, J. ^{[7
]}

Gorrochategui, J. ^{[1
]}

Vicente Ma, L. ^{[1
]}

Gomez, C. ^{[1
]}

Martinez Lopez, J. ^{[3
]}

Hernandez, P. ^{[1
]}

Ballesteros, J. ^{[1
]}

机构：

[1] Vivia Biotech, Madrid, Spain

[2] Hosp Univ & Politecn La Fe Valencia, Valencia, Spain

[3] Hosp Univ 12 Octubre, Madrid, Spain

[4] Hosp Badalona Germans Trias & Pujol, Badalona, Spain

[5] Hosp San Pedro de Alcantara, Caceres, Spain

[6] Hosp Univ Sanchinarro, Madrid, Spain

[7] Hosp Univ Reina Sofia, Cordoba, Spain

来源：

HAEMATOLOGICA | 2017年 / 102卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

CO-051

引用

页码：37 / 38

页数：2

共 50 条

[41] HUMANIZED BI-SPECIFIC ANTIBODY SHOWS POTENT ACTIVITY IN PATIENT-DERIVED XENOGRAFT MODELS OF GLIOBLASTOMA
Duffy, Joseph
Zannikou, Markella
Levine, Rebecca
Stupp, Roger
James, David
Balyasnikova, Irina
NEURO-ONCOLOGY, 2022, 24 : 132 - 132
[42] Simulating plant water stress dynamics in a wide range of bi-specific agrosystems in a region using the BISWAT model
Bertrand, Nicolas
Roux, Sebastien
Forey, Oswaldo
Guinet, Mae
Wery, Jacques
EUROPEAN JOURNAL OF AGRONOMY, 2018, 99 : 116 - 128
[43] Pharmacologic evaluation of bispecific antibodies: A novel method to quantify their in vitro activity in hematologic samples.
Primo, Daniel
Hernandez, Pilar
Gorrochategui, Julian
Luisa Vincente, Ma
Gomez, Cristina
Martinez Cuadron, David
Montesinos, Pau
Martinez-Lopez, Joaquin
Ballesteros, Joan
CLINICAL CANCER RESEARCH, 2017, 23 (24) : 46 - 47
[44] Phase I Experience with a Bi-Specific CAR Targeting CD19 and CD22 in Adults with B-Cell Malignancies
Hossain, Nasheed
Sahaf, Bita
Abramian, Matthew
Spiegel, Jay Y.
Kong, Katie
Kim, Stephen
Mavroukakis, Sharon
Oak, Jean
Natkunam, Yasodha
Meyer, Everett H.
Frank, Matthew J.
Feldman, Steven A.
Long, Steven R.
Qin, Haiying
Fry, Terry J.
Muffly, Lori S.
Mackall, Crystal L.
Miklos, David B.
BLOOD, 2018, 132
[45] Directing HIV-1 for degradation by non-target cells, using bi-specific single-chain llama antibodies
Stam, Jord C.
de Maat, Steven
de Jong, Dorien
Arens, Mathia
van Lint, Fenna
Gharu, Lavina
van Roosmalen, Mark H.
Roovers, Rob C.
Strokappe, Nika M.
Wagner, Ralf
Kliche, Alexander
de Haard, Hans J.
Henegouwen, Paul M. van Bergen en
Nijhuis, Monique
Verrips, C. Theo
SCIENTIFIC REPORTS, 2022, 12 (01)
[46] VALIDATION OF BI-SPECIFIC T-CELL ENGAGER (BITE®) ANTIBODY ACTIVITY IN VITRO AND IN VIVO AGAINST DIFFERENTIALLY EXPRESSED CELL SURFACE TARGETS IN ACUTE MYELOID LEUKEMIA
Sinclair, A. M.
Nazarian, A. A.
Homann, O.
Zhang, S.
Archibeque, I.
Busse, L.
Koppikar, P.
Hale, K.
Newhall, K.
Powers, D.
Foltz, I.
Moriguchi, J.
McElroy, T.
Manchulenko, K.
Moody, G.
Bakker, A.
HAEMATOLOGICA, 2014, 99 : 293 - 294
[47] INTRACELLULAR UPTAKE AND CATABOLISM OF ANTI-IGM ANTIBODIES AND BI-SPECIFIC ANTIBODY-TARGETED HAPTEN BY B-LYMPHOMA CELLS
MANETTI, C
LEDOUSSAL, JM
ROUVIER, E
GRUAZGUYON, A
BARBET, J
INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (02) : 250 - 256
[48] BI-SPECIFIC MONOCLONAL-ANTIBODIES - SELECTIVE BINDING AND COMPLEMENT-FIXATION TO CELLS THAT EXPRESS 2 DIFFERENT SURFACE-ANTIGENS
WONG, JT
COLVIN, RB
JOURNAL OF IMMUNOLOGY, 1987, 139 (04): : 1369 - 1374
[49] Humanized Bi-Specific Antibody Shows a Potent Activity in Primary and Therapy-Resistant Glioblastoma in Experimental Models of Disease
Zannikou, Markella
Levine, Rebecca Noa
Duffy, Joseph Thomas
Stupp, Roger
James, Charles David
Balyasnikova, Irina V.
MOLECULAR THERAPY, 2022, 30 (04) : 307 - 308
[50] Direct effect of bi-specific CD33 x CD64 antibodies on acute myeloid leukemia (AML) cells.
Balaian, L
Ball, ED
BLOOD, 1999, 94 (10) : 593A - 593A

← 1 2 3 4 5 →